Commun Biol. 2023 Jun 2;6(1):597. doi: 10.1038/s42003-023-04964-2. ABSTRACT Burn induces a systemic response affecting multiple organs, including the liver. Since the liver plays a critical… Read More »Transcriptomics, metabolomics, and in-silico drug predictions for liver damage in young and aged burn victims
On May 18-21, 2023. The LAMPE Lab presented several of their research works in poster or talk format.
In May 2023, Dr. Lampe was asked by Prof. Fred Guengerich to organize the 2027 International Conference on Cytochrome P450 (http://www.p450meetings.com/future/), which will be held right here in Denver, Colorado!
In April 2023, Dr. Lampe was invited to join the International Society for the Study of Xenobiotics (ISSX: https://www.issx.org/) Biotransformation, Mechanisms, and Pathways Focus Group steering committee. Congratulations, Dr. Lampe!
On February 7th, 2023. Dr. Lampe gave a presentation in the Department of Pharmacology at Dalhousie University (https://medicine.dal.ca/departments/department-sites/pharmacology.html) in Newfoundland, Canada entitled, “Discovery and development of natural product and PROTAC-based inhibitors of the SARS-CoV-2 main protease, Mpro”.
Per- and polyfluoroalkyl substances (PFAS) are a chemical class of highly stable, fluorinated compounds popular for use in a variety of consumer products. PFAS environmental… Read More »Per- and polyfluoroalkyl substances (PFAS) inhibit cytochrome P450 CYP3A7 through direct coordination to the heme iron and water displacement
On August 29-30, 2022, Michaela Hvizdak, the newest addition to the Lampe Lab, presented her research work on PFAS in both poster and talk formats.
